DR4

• DR4 is a specific allele of the HLA-DRB1 gene, also known as HLA-DRB1*04.
• It is a crucial component of the immune system, responsible for presenting antigens to T-cells.
• The presence of DR4 is associated with an increased genetic predisposition to several autoimmune diseases.
• Carrying the DR4 allele increases risk but does not guarantee the development of an autoimmune condition.

What is DR4 (HLA-DRB1*04)?

To learn about DR4, it’s essential to grasp its fundamental role in human genetics and immunology. DR4, specifically known as HLA-DRB1*04, is a particular allele of the HLA-DRB1 gene, which is part of the major histocompatibility complex (MHC) class II genes located on chromosome 6. The DR4 meaning and definition centers on its function as a genetic marker that encodes for a specific protein on the surface of certain immune cells.

These HLA proteins are vital for the immune system’s ability to distinguish between the body’s own cells (self) and foreign invaders (non-self). HLA-DRB1*04 is one of many variations (alleles) of the HLA-DRB1 gene. The specific structure of the DR4 protein influences which foreign peptides it can bind and present to T-cells, thereby shaping the immune response. This aspect of DR4 explained highlights its direct impact on immune recognition and regulation.

Role of DR4 in Immune Function

The primary role of DR4, like other HLA class II molecules, is to present processed foreign antigens (peptides) to CD4+ helper T-lymphocytes. When an antigen-presenting cell (APC) such as a macrophage or dendritic cell encounters a pathogen, it internalizes and breaks down the pathogen’s proteins into smaller peptides. These peptides are then loaded onto HLA class II molecules, including DR4, and displayed on the cell surface.

CD4+ T-cells, which are crucial orchestrators of adaptive immunity, recognize these presented peptides via their T-cell receptors. This recognition event is a critical step in initiating a targeted immune response, leading to the activation and proliferation of specific T-cells that can help eliminate the pathogen. The unique binding groove of DR4 determines which peptides it can present effectively, influencing the repertoire of T-cell responses an individual can mount.

DR4 and Associated Autoimmune Conditions

The presence of the DR4 allele is significantly associated with an increased genetic predisposition to several autoimmune diseases. In these conditions, the immune system mistakenly attacks the body’s own tissues. While carrying DR4 increases risk, it is not a sole determinant; environmental factors and other genetic elements also play crucial roles. The specific peptide-binding characteristics of DR4 may contribute to its association with autoimmunity by presenting self-peptides in a way that triggers an autoimmune response.

Notable autoimmune conditions linked to DR4 include:

• Rheumatoid Arthritis (RA): DR4 is one of the strongest genetic risk factors for RA, particularly the “shared epitope” alleles within the DRB1*04 group. Studies indicate that approximately 60-70% of individuals with rheumatoid arthritis of European descent carry the DR4 allele, compared to about 30% in the general population. (Source: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) data often cites similar figures in research literature.)
• Type 1 Diabetes Mellitus: While DR3 and DR4 often appear together as a high-risk combination, DR4 alone also contributes to susceptibility.
• Multiple Sclerosis (MS): Certain DR4 subtypes have been linked to an increased risk of developing MS.
• Systemic Lupus Erythematosus (SLE): Some studies suggest an association between DR4 and SLE, though the link may be less pronounced than with other HLA alleles.

It is important to remember that genetic markers like DR4 represent a predisposition, not a diagnosis. Individuals with DR4 may never develop an autoimmune disease, while others without DR4 may still develop them. Research continues to explore the complex interplay between genetics and environment in autoimmune disease development.